Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

46.47
+0.20000.43%
Post-market: 46.470.00000.00%19:14 EDT
Volume:2.19M
Turnover:101.34M
Market Cap:8.82B
PE:-13.14
High:46.76
Open:45.98
Low:45.73
Close:46.27
Loading ...

BridgeBio Pharma Is Maintained at Buy by Citigroup

Dow Jones
·
9 hours ago

BridgeBio price target raised to $67 from $58 at Citi

TIPRANKS
·
Yesterday

BridgeBio Pharma May Keep Outperforming as Attruby Sales Beat Consensus, Oppenheimer Says

MT Newswires Live
·
09 Jul

High Growth Tech Stocks To Watch In The US July 2025

Simply Wall St.
·
08 Jul

BridgeBio Pharma CEO Neil Kumar Reports Disposal of Common Shares

Reuters
·
04 Jul

BridgeBio Pharma Inc. Enters $300 Million Royalty Financing Agreement with Acoramidis Royalty SPV, LP and LSI Financing Fund, LP

Reuters
·
02 Jul

Viking Global Investors LP Reports Disposal of Common Shares of BridgeBio Pharma Inc

Reuters
·
02 Jul

Director Hannah Valantine Reports Disposal of Common Shares in BridgeBio Pharma Inc

Reuters
·
01 Jul

BridgeBio Pharma (BBIO) Receives a Buy from Citi

TIPRANKS
·
01 Jul

BridgeBio Pharma Is Maintained at Overweight by Wells Fargo

Dow Jones
·
30 Jun

BridgeBio Pharma Expands European Presence with $300 Million Royalty Monetization Deal for BEYONTTRA

Reuters
·
30 Jun

BridgeBio Raises $300 Million Through Partial Capped Monetization of Beyonttra® European Royalty

THOMSON REUTERS
·
30 Jun

Director Frank McCormick Reports Disposal of Common Shares of BridgeBio Pharma Inc

Reuters
·
27 Jun

BridgeBio Pharma Announces Upcoming Investor Webinar to Discuss Progress of LGMD2I/R9 Program and Phase 3 Trial Expectations

Reuters
·
26 Jun

BridgeBio Pharma Is Maintained at Buy by B of A Securities

Dow Jones
·
25 Jun

BridgeBio Pharma Inc : Bofa Global Research Raises Price Objective to $54 From $50

THOMSON REUTERS
·
25 Jun

BridgeBio price target raised to $54 from $50 at BofA

TIPRANKS
·
25 Jun

BridgeBio Pharma (BBIO) Gets a Buy from TD Cowen

TIPRANKS
·
24 Jun

BridgeBio Pharma Inc. Concluded Annual Stockholders Meeting

Reuters
·
24 Jun

Evercore ISI Remains a Buy on BridgeBio Pharma (BBIO)

TIPRANKS
·
23 Jun